Mark Thompson DO in Lake City, Florida

Home Florida Lake City

Mark Thompson DO has Radiation Oncology as his primary medical specialty. Their primary office is: 4520 W Us Hwy 90 in Lake City, Florida.

They're a part of the: Lake City Cancer Care Llc medical group which has around 8 members. You can call their office at 386-755-0601 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Philadelphia College Of Osteopathic Medicine and graduated in 1983 (around 41 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Mark E Thompson DO Office Phone and Directions

Mark Thompson DO
Lake City Cancer Care Llc
4520 W Us Hwy 90
Lake City, Florida 32055
386-755-0601

Patient Ratings
Please rate your experience with Mark Thompson DO below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 386-755-0601

Enter a starting address:

Healthcare Info for Mark Thompson DO

Medical School: Philadelphia College Of Osteopathic Medicine
Graduation Year: 1983
The Primary Medical Specialty for Mark Thompson DO is listed as: Radiation Oncology
Credentials: DO
Additional Credentials:
Approximate Years of Experience: 41
PAC (PECOS ID)#: 6002706983
NPI #: 1487646030
NPI Created On: 08/19/2005
NPI Last Updated Listed as: 02/16/2023
Primary Taxonomy Code: 2085R0001X
License Number:
OS10194
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Management of radiation therapy, complex
Management of radiation therapy simulation, simple
Management of radiation therapy, simulation, complex
Management of radiation therapy, 3d
Calculation of radiation therapy dose
Management of modulation radiotherapy planning
Radiation treatment devices, design and construction, complex
Radiation therapy consultation per week
Design and construction of device for radiation therapy
Radiation treatment management, 5 treatments
Nuclear medicine study with ct imaging skull base to mid-thigh
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 40 minutes
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
Fluciclovine f-18, diagnostic, 1 millicurie
Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788305451

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788305453

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788305455

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788305459

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788305457

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781018461

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796153645

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $32

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796153647

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 796153649

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: VENCLEXTA

Open Associated Drug #1: 0074-0576-22

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 818635387

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: VERZENIO

Open Associated Drug #1: 0002-6216-54

Radiation Oncology Professionals in Lake City

1.
Cherylle Hayes MD

795 Sw State Rd
Lake-city, FL
North Florida Radiation Oncology Llc

2.
Charles Perkins

795 Sw State Rd
Lake-city, FL
North Florida Radiation Oncology Llc

3.
Christopher Balamucki

795 Sw State Rd
Lake-city, FL
North Florida Radiation Oncology Llc

4.
Lori Grow MD

795 Sw State Rd
Lake-city, FL
North Florida Radiation Oncology Llc

Providers in Lake City Cancer Care Llc

1.Amir Abdelmalik

4520 W Us Hwy 90
Lake City Fl 32055-8341
Lake City Cancer Care Llc
Nuclear Medicine

2.Jessica Douglas

289 Sw Stonegate Ter
Lake City Fl 32024-3457
Lake City Cancer Care Llc
Nurse Practitioner

3.Jessica Douglas

4520 W Us Hwy 90
Lake City Fl 32055-8341
Lake City Cancer Care Llc
Nurse Practitioner

4.Waseemullah Khan Md

289 Sw Stonegate Ter
Lake City Fl 32024-3457
Lake City Cancer Care Llc
Hematology/oncology

5.Matthew Loughlin Md

289 Sw Stonegate Ter
Lake City Fl 32024-3457
Lake City Cancer Care Llc
Urology

6.Vernon Montoya Md

289 Sw Stonegate Ter
Lake City Fl 32024-3457
Lake City Cancer Care Llc
Medical Oncology

View all 8 members of Lake City Cancer Care Llc medical group